LNG-IUS与GnRHa方案治疗子宫腺肌病效果比较附视频

被引：10

作者：

涂灵

曹华斌

邬欢欢

机构：

[1] 江西省妇幼保健院

来源：

山东医药 | 2012年 / 30期

关键词：

子宫腺肌病; 促性腺激素释放激素激动剂; 左炔诺孕酮宫内释放系统;

D O I：

暂无

中图分类号：

R711.71 [子宫内膜异位症];

学科分类号：

100211 ;

摘要：

目的观察并比较左炔诺孕酮宫内释放系统(LNG-IUS,商品名曼月乐)和促性腺激素释放激素激动剂(GnRHa,商品名达菲林)方案治疗子宫腺肌病的效果。方法将40例子宫腺肌病患者随机分为曼月乐组与达菲林组,各20例。曼月乐组于月经周期第3～7天由专人宫内放置曼月乐,达菲林组在月经第1天注射达菲林,此后每隔28 d注射1次。观察两组治疗后痛经情况、月经量、子宫体积、子宫内膜厚度的变化,检测血清CA125水平。以后3个指标评价疗效。结果与治疗前相比,两组治疗后VAS改善、月经量明显减少(P均<0.05),血清CA125水平无明显变化(P均>0.05)。与治疗前比较,治疗后6个月曼月乐组子宫体积变化不明显(P>0.05),子宫内膜厚度明显变薄(P<0.05);达菲林组子宫体积变小(P<0.05),子宫内膜厚度改变不明显(P>0.05)。两组治疗后6个月子宫体积及血清CA125相比,P均<0.05。曼月乐组有效17例,无效3例,有效率为85%;达菲林组分别为18、2例和90%,两组有效率相比,P>0.05。两组同期(治疗6个月)治疗费用分别为1 330、11 184元,两组相比,P<0.01。结论 LNG-IUS方案与GnRHa方案治疗子宫腺肌病疗效相近,但曼月乐较达菲林更为经济。

引用

页码：7 / 9

页数：3

共 18 条

[1]

Emerging indications for thelevonorgestrel releasing intrauterine system (LNG-IUS). Heikinheimo O,Gemzell Danielsson K. Acta Obstetrica et Gynecologica Scandinavica . 2012

[2]

Safety,efficacy and patient acceptabilityof the contraceptive and non-contraceptive uses of the LNG-IUS. Bednarek PH,Jensen JT. Int J Womens Health . 2010

[3]

Comparison oflevonorgest rel int rauterine system versus hysterectomy on efficacyand quality of life in patients with adenomyosis. Ozdegirmenci O,Kayikcioglu F,Akgul MA,et al. Fertility and Sterility . 2011

[4]

Effects of LNG-IUS on nervegrowth factor and its receptors expression in patients with adenomy-osis. Yesim B,Tekin MD,Berna D,et al. Growth Factors . 2010

[5]

Treatment of adenomyosis with long term GnRH analogues: a case report. Grow DR,Filer RB. Obstetrics and Gynecology . 1991

[6]

Assessment of menstrualblood loss using a pictorialchart. Higham JM,O’’Brien PMS,Shaw RW. British Journal of Obstetrics and Gynaecology . 1990

[7]

子宫肌腺病临床误诊原因探讨[J]. 刘伯宁,陆丽华. 用妇产科杂志. 1993 (06)

[8] Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis [J].

Ozdegirmenci, Ozlem ;

Kayikcioglu, Fulya ;

Akgul, Mehmet Akif ;

Kaplan, Metin ;

Karcaaltincaba, Musturay ;

Haberal, Ali ;

Akyol, Mesut .

FERTILITY AND STERILITY, 2011, 95 (02) :497-502

[9]

Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparativestudy withthe GnRH analogue. Ferreira RA,Vieira CS,Rosa-E-Silva JC,etal. Contraception . 2010

[10]

Levonorgestrel-releasing intra-uterine system and combined oral contraceptives as conservativetreatments for recurrent ovarian endometriosis:a comparative clini-cal study. Xu XW,Wang LD,Zhu XQ,et al. Chinese Medical Journal . 2011

← 1 2 →